NCT03320759

Brief Summary

The investigators have spent the last decade uncovering unique metabolic and functional abnormalities in the brains of patients with spinal cord compression. Degenerative spinal cord compression represents a unique model of reversible spinal cord injury. In the investigator's previous work, they have demonstrated that cortical reorganization and recruitment is associated with metabolic changes in the brains of patients recovering from spinal cord compression and is correlated with recovery and improved neurological scores. The goal of this study is to combine a rigorous platform of clinical care that includes preoperative evaluation, surgery, and rehabilitation, with state of the art imaging techniques to demonstrate how rehabilitative therapy can increase brain plasticity and recovery of neurological function in patients with spinal cord injury. Neurological function will be carefully evaluated in two groups of patients, those receiving rehabilitation and those not receiving rehabilitation after spine surgery, and will be correlated with the results of advanced imaging.

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
40

participants targeted

Target at P25-P50 for not_applicable

Timeline
2mo left

Started Aug 2018

Longer than P75 for not_applicable

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress98%
Aug 2018Jul 2026

First Submitted

Initial submission to the registry

September 27, 2017

Completed
28 days until next milestone

First Posted

Study publicly available on registry

October 25, 2017

Completed
10 months until next milestone

Study Start

First participant enrolled

August 21, 2018

Completed
7.3 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 1, 2025

Completed
7 months until next milestone

Study Completion

Last participant's last visit for all outcomes

July 1, 2026

Expected
Last Updated

March 28, 2024

Status Verified

March 1, 2024

Enrollment Period

7.3 years

First QC Date

September 27, 2017

Last Update Submit

March 26, 2024

Conditions

Outcome Measures

Primary Outcomes (4)

  • Changes in levels of N-acetylaspartate (NAA) in the motor cortex

    It is expected that the group of patients receiving rehabilitation will experience less decline in NAA concentrations as compared to the second group of patients not receiving rehabilitation.

    Measured and reported for all follow-ups throughout study (i.e. pre-operatively, 4 weeks, 6 weeks, 6 months)

  • Changes to volume of activation in motor and supplementary motor cortices

    Volume of activation is measured by calculating the voxel number within our selected cortical regions, the motor cortex and supplementary motor cortex, using functional magnetic resonance imaging (fMRI). Changes in these numbers demonstrate volume of cortical activation changes in these regions. Following rehabilitation, the investigators expect that the volume of cortical activation of patients, expressed as voxel number, will change between time points compared with changes observed in the control group.

    Measured and reported for all follow-ups throughout study (i.e. pre-operatively, 4 weeks, 6 weeks, 6 months)

  • Changes in Graded Redefined Assessment of Strength, Sensibility, and Prehension (GRASSP) scores

    Graded Redefined Assessment of Strength, Sensibility, and Prehension (GRASSP) is an indicator of dorsal and palmar sensation, strength (by myotome) and prehension (grasping). GRASSP is a standardized measure to assess hand function in ways that are meaningful in the context of a patient's overall ability to complete activities of daily living.

    Measured and reported for all follow-ups throughout study (i.e. pre-operatively, 4 weeks, 6 weeks, 6 months)

  • Changes to intensity of cortical activation in motor and supplementary motor cortices

    Intensity of cortical activation is expressed as signal intensity in beta weights. Following rehabilitation, the investigators expect that the intensity of cortical activation in participants in the intervention group will change between time-points compared with changes observed in the control group.

    Measured and reported for all follow-ups throughout study (i.e. pre-operatively, 4 weeks, 6 weeks, 6 months)

Secondary Outcomes (5)

  • RAND Short form (SF)-36 Health Survey Questionnaire

    Measured and reported for all follow-ups throughout study (i.e. pre-operatively, 4 weeks, 6 weeks, 6 months)]

  • Modified Japanese Orthopaedic Association (mJOA) scale

    Measured and reported for all follow-ups throughout study (i.e. pre-operatively, 4 weeks, 6 weeks, 6 months)

  • Myelopathy Disability Index (MDI)

    Measured and reported for all follow-ups throughout study (i.e. pre-operatively, 4 weeks, 6 weeks, 6 months)

  • American Spinal Injury Association (ASIA) Impairment Scale

    Measured and reported for all follow-ups throughout study (i.e. pre-operatively, 4 weeks, 6 weeks, 6 months)

  • Strength as tested with hand dynamometer

    Measured and reported for all follow-ups throughout study (i.e. pre-operatively, 4 weeks, 6 weeks, 6 months)

Study Arms (2)

No rehabilitation

NO INTERVENTION

Rehabilitation

EXPERIMENTAL
Behavioral: Occupational therapy rehabilitation

Interventions

Participants in the experimental arm will receive occupational therapy that is individualized to each participant's needs from week 4 post-decompression surgery until week 12.

Rehabilitation

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • right-handed
  • have a history of progressive neurological deficits \<24 months
  • eligible for MRI scanning

You may not qualify if:

  • having any other neurological disorder or systemic disease that can impair neurological function
  • not fluent in reading and speaking English
  • being claustrophobic
  • unable to follow simple task instructions and maintain standardized movements
  • being unable to return for all follow-up imaging and rehabilitation sessions

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

LHSC - University Hospital

London, Ontario, N6A 5A5, Canada

RECRUITING

MeSH Terms

Conditions

Spinal Cord CompressionSpinal Cord InjuriesSpondylosis

Condition Hierarchy (Ancestors)

Spinal Cord DiseasesCentral Nervous System DiseasesNervous System DiseasesWounds and InjuriesTrauma, Nervous SystemSpinal DiseasesBone DiseasesMusculoskeletal Diseases

Central Study Contacts

Sarah Detombe, PhD

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

September 27, 2017

First Posted

October 25, 2017

Study Start

August 21, 2018

Primary Completion

December 1, 2025

Study Completion (Estimated)

July 1, 2026

Last Updated

March 28, 2024

Record last verified: 2024-03

Locations